课题基金 / 基金详情

PAR mediated Rap 1 activation in platelets

PAR mediated Rap 1 activation in platelets
PAR 介导血小板中 Rap 1 的激活
批准号:
7113603
负责人:
MICHAEL Allan HOLINSTAT
金额:
$4.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-01 至 2007-07-31

项目摘要

项目成果

MICHAEL Allan HOLINSTAT的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):凝血酶是血小板最有效的激活剂之一,通过激活G蛋白偶联蛋白酶受体PAR-1和PAR-4起作用,激活后导致细胞内钙增加,Rap1激活并最终导致血小板聚集,PAR信号系统被认为是抑制血小板激活的一个位点,因为阻断PAR信号被认为是降低其他抗血小板治疗中观察到的出血风险的关键。
英文摘要
DESCRIPTION (provided by applicant): Thrombin, one of the most potent activators of platelets, works through activation of G protein-coupled protease receptors PAR-1 and PAR-4, which upon activation lead to increases in intracellular calcium, Rap1 activation and finally platelet aggregation, the PAR signaling system has been targeted as a site for inhibiting platelet activation because blocking PAR signaling is thought to be crucial in decreasing the risk to bleeding observed in other anti-platelet therapies. The aim of this research proposal is to identify how thrombin may differentially signal Rap1 mediated platelet activation. Since Rap1 has been implicated in thrombin-induced activation of platelets and may be a crucial mediator signaling inside-out activation of integrin receptor GPIIbllla as well as activating other downstream signaling pathways, I propose to investigate, through the use of specific PAR inhibitors and G protein minigenes, the differential signaling involved from the PAR receptors to Rap1, what this difference in signaling translates to in the form of level of platelet activation and by what means Rap1 is able to activate aggregation and/or secretion in platelets following thrombin, PAR-1 or PAR-4.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
2022 Midwest Platelet Conference
Biomarkers for 12-lipoxygenase inhibition as a therapeutic intervention for heparin-induced thrombocytopenia and thrombosis (HIT/T)
  • 批准号:
    10427382
  • 项目类别:
  • 资助金额:
    $23.36万
  • 财政年份:
    2021
  • 负责人:
    MICHAEL Allan HOLINSTAT
  • 依托单位:
Biomarkers for 12-lipoxygenase inhibition as a therapeutic intervention for heparin-induced thrombocytopenia and thrombosis (HIT/T)
  • 批准号:
    10177358
  • 项目类别:
  • 资助金额:
    $20.86万
  • 财政年份:
    2021
  • 负责人:
    MICHAEL Allan HOLINSTAT
  • 依托单位:
12-HETrE regulation of blood coagulation, hemostasis, and thrombosis
国内基金
海外基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
基于NLRP3/IL-1β信号探讨α7nAChR介导巨噬细胞—心肌细胞互作在Aβ诱导房颤心房重构中的作用及机制研究
Tom1L1在胞内体蛋白分选机制中功能的研究
  • 批准号:
    31171289
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2011
  • 负责人:
    刘宁生
  • 依托单位:
溶酶体依赖性TRAF2降解的机制
  • 批准号:
    30971501
  • 项目类别:
    面上项目
  • 资助金额:
    31.0万元
  • 批准年份:
    2009
  • 负责人:
    李联运
  • 依托单位: